首页> 外文期刊>American Journal of Biochemistry and Biotechnology >Docking and Molecular Dynamics Simulations in Potential Drugs Discovery: An Application to Influenza Virus M2 Protein
【24h】

Docking and Molecular Dynamics Simulations in Potential Drugs Discovery: An Application to Influenza Virus M2 Protein

机译:潜在药物发现中的对接和分子动力学模拟:流感病毒M2蛋白的应用

获取原文
       

摘要

Molecular docking is a common method for searching new potential drugs. Improvement of the results of docking can be achieved by different ways-one of them is molecular dynamics simulations of protein-ligand complexes. As a model for our research we chose M2 membrane protein from influenza virus. M2 protein is a high selective tetrameric pH-gated proton channel. It was previously shown that Omeprazole Family Compounds (OFC) block the "proton pump", though we hypothesized further that they could interfere with the mechanism of fusion of the virus envelope and endosomal membrane, thereby hindering the M2 proton pump mechanism of influenza viruses. We carried out a Molecular Dynamics (MD) simulation in order to predict constant of binding for OFC. We simulated M2 Protein (PDB code 3C9J) in complex with its ligands: Amantadine, rimantadine as positive controls and omeprazole as putative ligand. We made use of molecular docking as well as the thermodynamic integration method to estimate binding free energies of the ligands. We demonstrate that the thermodynamic integration method predicts free energies of ligand binding better than molecular docking while embedding of M2 protein in a membrane further improves the calculated free energy values. Free energy calculations imply omeprazole as a potent anti-viral drug.
机译:分子对接是寻找新的潜在药物的常用方法。可以通过不同的方式来改善对接结果,其中之一是蛋白质-配体复合物的分子动力学模拟。作为我们研究的模型,我们从流感病毒中选择了M2膜蛋白。 M2蛋白是高选择性的四聚体pH门控质子通道。先前已显示奥美拉唑家族化合物(OFC)阻止了“质子泵”,尽管我们进一步假设它们可能干扰病毒包膜和内体膜融合的机制,从而阻碍了流感病毒的M2质子泵机制。我们进行了分子动力学(MD)模拟,以预测OFC的结合常数。我们模拟了M2蛋白(PDB代码3C9J)及其配体:金刚烷胺,金刚乙胺作为阳性对照,奥美拉唑作为假定配体。我们利用分子对接以及热力学积分方法来估计配体的结合自由能。我们证明,热力学整合方法比分子对接更好地预测配体结合的自由能,而将M2蛋白嵌入膜中则进一步提高了计算出的自由能值。自由能计算表明奥美拉唑是有效的抗病毒药物。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号